Clinical trial
Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine
NCT00210288 · Institut Pasteur, Industry · Completed
Key facts
| NCT number | NCT00210288 |
|---|---|
| Title | Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine |
| Official title | A Comparative Double Blind Placebo-Controlled Study of Immunogenicity and Safety of Two Doses 10^5 and 10^7 CFU of SC599 Oral Vaccine, a Live Attenuated Shigella Dysenteriae 1 Vaccine Strain in Healthy Human Adult Volunteers |
| Lead sponsor | Institut Pasteur, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Shigella Infection |
| Intervention type | Biological |
| Interventions | SC599 |
| Enrollment | 111 |
| Start date | May 1, 2005 |
| Primary completion | Sep 1, 2006 |
| Completion | Apr 1, 2007 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 8, 2018 |
| Countries | France, United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: